Cargando…
Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus
Recently, the use of oncolytic viruses in cancer therapy has become a realistic therapeutic option. Seneca Valley Virus (SVV) is a newly discovered picornavirus, which has earned a significant reputation as a potent oncolytic agent. Anthrax toxin receptor 1 (ANTXR1), one of the cellular receptors fo...
Autores principales: | Jayawardena, Nadishka, Burga, Laura N., Easingwood, Richard A., Takizawa, Yoshimasa, Wolf, Matthias, Bostina, Mihnea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243253/ https://www.ncbi.nlm.nih.gov/pubmed/30381454 http://dx.doi.org/10.1073/pnas.1810664115 |
Ejemplares similares
-
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection
por: Jayawardena, Nadishka, et al.
Publicado: (2021) -
Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes
por: Sergeeva, Oksana A., et al.
Publicado: (2019) -
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
por: Jayawardena, Nadishka, et al.
Publicado: (2019) -
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
por: Jayawardena, Nadishka, et al.
Publicado: (2020) -
Developing Picornaviruses for Cancer Therapy
por: McCarthy, Cormac, et al.
Publicado: (2019)